-
1
المؤلفون: Bekkering, WP, Vliet Vlietland, Th, Koopman, HM, Schaap, GR, Schreuder, HWB, Beishuizen, Auke, Tissing, WJE, Hoogerbrugge, PM (Peter), Anninga, JK, Taminiau, AHM
المساهمون: Pediatrics
المصدر: Pediatric Blood & Cancer, 53, 348-355. Wiley-Liss Inc.
وصف الملف: application/pdf
-
2دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
3دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
4دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
5دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
6دورية أكاديمية
لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل. -
7دورية أكاديمية
المؤلفون: Postema FAM; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hopman SMJ; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., de Borgie CAJM; Clinical Research Unit, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Aalfs CM; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Anninga JK; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Berger LPV; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Bleeker FE; Department of Clinical Genetics, Netherlands Cancer Institute, Amsterdam, The Netherlands., Dommering CJ; Department of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., van Eijkelenburg NKA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hammond P; Nuffield Department of Obstetrics and Gynecology, University of Oxford, Oxford, UK., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Hol JA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kors WA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Letteboer TGW; Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands., Loeffen JLCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Meijer L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Olderode-Berends MJW; Department of Genetics, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Wagner A; Department of Clinical Genetics, Erasmus Medical Center, Rotterdam, The Netherlands., Hennekam RC; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Merks JHM; Department of Pediatrics, Emma Children's Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands. j.h.m.merks@prinsesmaximacentrum.nl.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.h.m.merks@prinsesmaximacentrum.nl.
المصدر: Familial cancer [Fam Cancer] 2021 Oct; Vol. 20 (4), pp. 263-271. Date of Electronic Publication: 2021 Mar 09.
نوع المنشور: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Springer Country of Publication: Netherlands NLM ID: 100898211 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7292 (Electronic) Linking ISSN: 13899600 NLM ISO Abbreviation: Fam Cancer Subsets: MEDLINE
مواضيع طبية MeSH: Neoplasms*/diagnosis , Neoplasms*/genetics, Child ; Early Detection of Cancer ; Humans ; Mass Screening ; Prospective Studies ; Syndrome
-
8دورية أكاديمية
المؤلفون: Lancia C; Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands. c.lancia@math.leidenuniv.nl., Anninga JK; Department Paediatric Oncology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands., Sydes MR; MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, UCL and MRC London Hub for Trials Methodology Research, 90 High Holborn, London, WC1V 6LJ, UK., Spitoni C; Mathematical Institute Utrecht University, Budapestlaan 6, 3584 CD, Utrecht, The Netherlands. c.spitoni@uu.nl.; Department of Epidemiology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. c.spitoni@uu.nl., Whelan J; Department of Oncology, University College London Hospital, 235 Euston Rd, Fitzrovia, London, NW1 2BU, UK., Hogendoorn PCW; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Gelderblom H; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Fiocco M; Mathematical Institute Leiden University, Niels Bohrweg 1, 2333 CA, Leiden, The Netherlands.; Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
المصدر: Cancer chemotherapy and pharmacology [Cancer Chemother Pharmacol] 2019 May; Vol. 83 (5), pp. 951-962. Date of Electronic Publication: 2019 Mar 16.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't
بيانات الدورية: Publisher: Springer Verlag Country of Publication: Germany NLM ID: 7806519 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0843 (Electronic) Linking ISSN: 03445704 NLM ISO Abbreviation: Cancer Chemother Pharmacol Subsets: MEDLINE
مواضيع طبية MeSH: Antineoplastic Combined Chemotherapy Protocols/*administration & dosage , Bone Neoplasms/*drug therapy , Osteosarcoma/*drug therapy, Disease-Free Survival ; Dose-Response Relationship, Drug ; Humans ; Randomized Controlled Trials as Topic ; Retrospective Studies ; Time Factors ; Treatment Outcome
-
9دورية أكاديمية
المؤلفون: Postema FA; Department of Paediatric Oncology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands., Hopman SM; Department of Paediatric Oncology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands.; Department of Genetics, University Medical Centre Utrecht, Utrecht, The Netherlands., de Borgie CA; Clinical Research Unit, Academic Medical Centre, Amsterdam, The Netherlands., Hammond P; Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK., Hennekam RC; Department of Paediatrics, Academic Medical Centre, Amsterdam, The Netherlands., Merks JH; Department of Paediatric Oncology, Emma Children's Hospital, Academic Medical Centre, Amsterdam, The Netherlands., Aalfs CM, Anninga JK, Berger LP, Bleeker FE, de Bont ES, de Borgie CA, Dommering CJ, van Eijkelenburg NK, Hammond P, Hennekam RC, van den Heuvel-Eibrink MM, Hopman SM, Jongmans MC, Kors WA, Letteboer TG, Loeffen JL, Merks JH, Olderode-Berends MJ, Postema FA, Wagner A
مؤلفون مشاركون: TuPS study group, TuPS study group
المصدر: BMJ open [BMJ Open] 2017 Jan 20; Vol. 7 (1), pp. e013237. Date of Electronic Publication: 2017 Jan 20.
نوع المنشور: Journal Article; Multicenter Study; Validation Study
بيانات الدورية: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101552874 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-6055 (Electronic) Linking ISSN: 20446055 NLM ISO Abbreviation: BMJ Open Subsets: MEDLINE
مواضيع طبية MeSH: Genetic Diseases, Inborn/*diagnosis , Mass Screening/*methods , Neoplasms/*genetics, Adolescent ; Checklist ; Child ; Child, Preschool ; Female ; Genetic Predisposition to Disease ; Humans ; Infant ; Infant, Newborn ; Male ; Neoplasms/etiology ; Netherlands ; Photography ; Prospective Studies ; Research Design ; Syndrome
-
10دورية أكاديمية
المؤلفون: van Oosterwijk JG; Department of Pathology, Leiden University Medical Center, PO Box 9600, L1-Q, Leiden RC 2300, The Netherlands., Anninga JK, Gelderblom H, Cleton-Jansen AM, Bovée JV
المصدر: Hematology/oncology clinics of North America [Hematol Oncol Clin North Am] 2013 Oct; Vol. 27 (5), pp. 1021-48. Date of Electronic Publication: 2013 Aug 26.
نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't; Review
بيانات الدورية: Publisher: Elsevier Health Science Country of Publication: United States NLM ID: 8709473 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1558-1977 (Electronic) Linking ISSN: 08898588 NLM ISO Abbreviation: Hematol Oncol Clin North Am Subsets: MEDLINE
مواضيع طبية MeSH: Bone Neoplasms/*pathology , Bone Neoplasms/*therapy , Chondrosarcoma/*pathology , Chondrosarcoma/*therapy , Osteosarcoma/*pathology , Osteosarcoma/*therapy, Humans ; Neoplasm Grading